Genpact Limited (NYSE:G) to Issue Quarterly Dividend of $0.09

Genpact Limited (NYSE:G) announced a quarterly dividend on Thursday, October 17th, Zacks reports. Shareholders of record on Monday, December 9th will be given a dividend of 0.085 per share by the business services provider on Wednesday, December 18th. This represents a $0.34 annualized dividend and a yield of 0.85%. The ex-dividend date is Friday, December 6th.

G stock opened at $40.20 on Wednesday. The firm has a 50-day moving average price of $39.61 and a 200-day moving average price of $38.93. Genpact has a 12 month low of $25.48 and a 12 month high of $44.55. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $7.73 billion, a P/E ratio of 25.13, a price-to-earnings-growth ratio of 2.14 and a beta of 0.79.

Genpact (NYSE:G) last released its quarterly earnings data on Thursday, November 7th. The business services provider reported $0.56 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.04. The business had revenue of $888.80 million during the quarter, compared to analysts’ expectations of $884.91 million. Genpact had a net margin of 8.84% and a return on equity of 21.42%. The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.48 EPS. As a group, equities analysts predict that Genpact will post 1.7 EPS for the current fiscal year.

G has been the topic of several recent research reports. Deutsche Bank raised their price objective on Genpact from $36.00 to $44.00 and gave the company a “hold” rating in a report on Thursday, August 8th. Wedbush lifted their price target on Genpact from $33.00 to $45.00 and gave the company a “neutral” rating in a research note on Thursday, August 8th. Cantor Fitzgerald lifted their price target on Genpact from $40.00 to $47.00 and gave the company an “overweight” rating in a research note on Thursday, August 8th. Zacks Investment Research upgraded Genpact from a “sell” rating to a “hold” rating and set a $43.00 price target on the stock in a report on Thursday, September 12th. Finally, ValuEngine downgraded Genpact from a “buy” rating to a “hold” rating in a research note on Friday, September 27th. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $40.18.

In other news, Director David Humphrey sold 12,916,004 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $39.87, for a total transaction of $514,961,079.48. Following the completion of the sale, the director now directly owns 34,907 shares in the company, valued at $1,391,742.09. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.86% of the company’s stock.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

See Also: Net Margin – Understanding the Different Kinds of Profit

Dividend History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.